Margaret M. Whalen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Margaret M. Whalen has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
Sabah O. Odman-Ghazi
Department of Biological Sciences, Tennessee State University, Nashville, TN 37209, USA
5 shared publications- Bommanna G. Loganathan
Murray State University
4 shared publications Fred D. Dudimah
Department of Biological Sciences, Tennessee State University, Nashville, TN 37209, USA
4 shared publicationsSahra Gabure
Department of Chemistry, Tennessee State University, Nashville, USA
4 shared publicationsShyretha Brown
Department of Biological Sciences, Tennessee State University, Nashville, TN, 37209, USA
4 shared publicationsAleshia Seaton-Terry
Departments of Biology, Tennessee State University, Nashville, USA
3 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by Wiley in Journal of Applied Toxicology
Toll‐Like Receptors in the Mechanism of Hexabromocyclododecane‐Induced Production of Pro‐Inflammatory Cytokines
Hexabromocyclododecane (HBCD), a brominated flame retardant, has raised increasing health concerns due to its bioaccumulation in human tissues and its ability to induce proinflammatory cytokines. Interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α) are major mediators of inflammation, and their chronic elevation contributes to autoimmune disorders, cardiovascular disease, and cancer. Previous studies have implicated mitogen‐activated protein kinases (MAPKs) as mediators of HBCD‐induced IL‐1β and IL‐6 production. Because MAPKs act downstream of Toll‐like receptors (TLRs)—key inflammatory response regulators, identifying whether TLRs contribute to HBCD‐driven inflammation is essential. This study examined the roles of TLR1/2, TLR2, TLR3, TLR4, and TLR8 in HBCD‐induced IL‐1β, IL‐6, and TNF‐α production in peripheral blood mononuclear cells (PBMCs). PBMCs were pretreated with selective inhibitors targeting TLR1/2 (CUCPT 22), TLR2 (C29), TLR3 (CUCPT 4a), TLR4 (TAK‐242), TLR8 (CUCPT 9a), and MyD88 (TJ‐M2010‐5), followed by exposure to HBCD (1–5 μM). The results indicated that inhibition of TLR4 significantly reduced HBCD‐induced production of all three cytokines, demonstrating its central roles in this response. Blocking TLR8 significantly reduced HBCD‐induced IL‐1β production. In contrast, inhibition of TLR1/2, TLR2, or TLR3 produced no consistent effects on HBCD‐induced cytokine production. Inhibition of the TLR‐associated adaptor protein MyD88 significantly attenuated HBCD‐induced IL‐1β and IL‐6 production, whereas TNF‐α production was not consistently affected. These results further elucidate the mechanism by which HBCD leads to elevation of pro‐inflammatory cytokine production by human immune cells.
- 26 August 2026
- Published by Wiley in Journal of Applied Toxicology
Open AccessToll‐Like Receptors in the Mechanism of Hexabromocyclododecane‐Induced Production of Pro‐Inflammatory Cytokines
Hexabromocyclododecane (HBCD), a brominated flame retardant, has raised increasing health concerns due to its bioaccumulation in human tissues and its ability to induce proinflammatory cytokines. Interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α) are major mediators of inflammation, and their chronic elevation contributes to autoimmune disorders, cardiovascular disease, and cancer. Previous studies have implicated mitogen‐activated protein kinases (MAPKs) as mediators of HBCD‐induced IL‐1β and IL‐6 production. Because MAPKs act downstream of Toll‐like receptors (TLRs)—key inflammatory response regulators, identifying whether TLRs contribute to HBCD‐driven inflammation is essential. This study examined the roles of TLR1/2, TLR2, TLR3, TLR4, and TLR8 in HBCD‐induced IL‐1β, IL‐6, and TNF‐α production in peripheral blood mononuclear cells (PBMCs). PBMCs were pretreated with selective inhibitors targeting TLR1/2 (CUCPT 22), TLR2 (C29), TLR3 (CUCPT 4a), TLR4 (TAK‐242), TLR8 (CUCPT 9a), and MyD88 (TJ‐M2010‐5), followed by exposure to HBCD (1–5 μM). The results indicated that inhibition of TLR4 significantly reduced HBCD‐induced production of all three cytokines, demonstrating its central roles in this response. Blocking TLR8 significantly reduced HBCD‐induced IL‐1β production. In contrast, inhibition of TLR1/2, TLR2, or TLR3 produced no consistent effects on HBCD‐induced cytokine production. Inhibition of the TLR‐associated adaptor protein MyD88 significantly attenuated HBCD‐induced IL‐1β and IL‐6 production, whereas TNF‐α production was not consistently affected. These results further elucidate the mechanism by which HBCD leads to elevation of pro‐inflammatory cytokine production by human immune cells.
- Open Access
- 25 August 2026
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (12) , 5497-5512
The role of toll-like receptors in tributyltin-, dibutyltin-, and pentachlorophenol-induced stimulation of tumor necrosis factor-alpha (TNFα) production in human immune cells
Tributyltin (TBT), Dibutyltin (DBT), and Pentachlorophenol (PCP) are persistent environmental contaminants that increase immune-cell production of pro-inflammatory cytokines and thus have the capacity to cause chronic inflammation and its associated pathologies such as cancer, cardiovascular disorders, and autoimmune conditions. TBT has been detected in human blood at concentrations up to 260 nM, DBT up to 0.3 µM, and PCP between 0.15 and 5 µM. Tumor necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine produced by immune cells in response to pathogen- or damage-associated molecular patterns (PAMPs/DAMPs) via Toll-like receptors (TLRs). Dysregulated TNF-α production contributes to chronic inflammatory pathology. Previous studies have shown that TBT, DBT, and PCP increase pro-inflammatory cytokine production by immune cells and that these increases depend on mitogen-activated protein kinases (MAPKs), which are downstream components of TLR activation. The current study indicates that TLR4 plays a role in TBT-, DBT-, and PCP-induced production of TNF-α. Additionally, TBT-induced TNF-α production was, at least in part, dependent on TLR2, DBT-induced TNF-α production on TLR1/2 and PCP-induced TNF-α production on TLR3 and TLR8. Blocking the initial component of TLR1/2, TLR2, TLR4, and TLR8 signaling, MyD88, led to very significant blockade of TBT- and PCP-induced TNF-α production. These findings provide additional understanding as to how compounds that are persistent pollutants activate production of a crucial regulator of inflammation, TNF-α, potentially contributing to chronic inflammation and its associated diseases.
- 25 August 2026
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (12) , 5497-5512
Open AccessThe role of toll-like receptors in tributyltin-, dibutyltin-, and pentachlorophenol-induced stimulation of tumor necrosis factor-alpha (TNFα) production in human immune cells
Tributyltin (TBT), Dibutyltin (DBT), and Pentachlorophenol (PCP) are persistent environmental contaminants that increase immune-cell production of pro-inflammatory cytokines and thus have the capacity to cause chronic inflammation and its associated pathologies such as cancer, cardiovascular disorders, and autoimmune conditions. TBT has been detected in human blood at concentrations up to 260 nM, DBT up to 0.3 µM, and PCP between 0.15 and 5 µM. Tumor necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine produced by immune cells in response to pathogen- or damage-associated molecular patterns (PAMPs/DAMPs) via Toll-like receptors (TLRs). Dysregulated TNF-α production contributes to chronic inflammatory pathology. Previous studies have shown that TBT, DBT, and PCP increase pro-inflammatory cytokine production by immune cells and that these increases depend on mitogen-activated protein kinases (MAPKs), which are downstream components of TLR activation. The current study indicates that TLR4 plays a role in TBT-, DBT-, and PCP-induced production of TNF-α. Additionally, TBT-induced TNF-α production was, at least in part, dependent on TLR2, DBT-induced TNF-α production on TLR1/2 and PCP-induced TNF-α production on TLR3 and TLR8. Blocking the initial component of TLR1/2, TLR2, TLR4, and TLR8 signaling, MyD88, led to very significant blockade of TBT- and PCP-induced TNF-α production. These findings provide additional understanding as to how compounds that are persistent pollutants activate production of a crucial regulator of inflammation, TNF-α, potentially contributing to chronic inflammation and its associated diseases.
- 6 February 2025
- Published by Wiley in Journal of Applied Toxicology
- Vol. 45 (6) , 976-993
Toll‐Like Receptors in Pentachlorophenol‐ and Dibutyltin‐Induced Production of Pro‐Inflammatory Cytokines, Interleukin (IL)‐1β, and IL‐6, by Human Immune Cells
Pentachlorophenol (PCP) and dibutyltin dichloride (DBT) contaminate the environment due to their diverse applications. PCP has been found from 0.26 to 5 μM in the serum of exposed individuals and at an average of 0.15 μM in the unexposed. DBT has been detected in human blood at levels up to 0.3 μM. Exposure to these contaminants is linked to pathological conditions including cancer. Interleukin‐1 beta (IL‐1β) and IL‐6 are pro‐inflammatory cytokines that when produced inappropriately can cause chronic inflammation, which is linked to pathologies including autoimmune diseases and cancer. PCP and DBT have been shown to increase the production of IL‐1β and IL‐6 by immune cells in a MAP kinase (MAPK) dependent process. Toll‐like receptors (TLRs) activate the signaling pathways linked to MAPK that lead to production of these cytokines. This study demonstrates that PCP‐induced production of IL‐1β and IL‐6 is dependent on TLR4 and TLR8, and independent of TLR1/2, TLR2, and TLR3. Additionally, DBT‐induced IL‐6 production depends on TLR1/2, whereas IL‐1β production does not. Blocking the TLR‐linked adapter protein, MyD88, lead to a loss of both PCP and DBT stimulation of IL‐1β and IL‐6. These findings indicate that both PCP and DBT interact with selected TLRs as part of their mechanisms of elevating the levels of critical pro‐inflammatory cytokines, which may contribute to chronic inflammation and its related pathologies.
- 6 February 2025
- Published by Wiley in Journal of Applied Toxicology
- Vol. 45 (6) , 976-993
Toll‐Like Receptors in Pentachlorophenol‐ and Dibutyltin‐Induced Production of Pro‐Inflammatory Cytokines, Interleukin (IL)‐1β, and IL‐6, by Human Immune Cells
Pentachlorophenol (PCP) and dibutyltin dichloride (DBT) contaminate the environment due to their diverse applications. PCP has been found from 0.26 to 5 μM in the serum of exposed individuals and at an average of 0.15 μM in the unexposed. DBT has been detected in human blood at levels up to 0.3 μM. Exposure to these contaminants is linked to pathological conditions including cancer. Interleukin‐1 beta (IL‐1β) and IL‐6 are pro‐inflammatory cytokines that when produced inappropriately can cause chronic inflammation, which is linked to pathologies including autoimmune diseases and cancer. PCP and DBT have been shown to increase the production of IL‐1β and IL‐6 by immune cells in a MAP kinase (MAPK) dependent process. Toll‐like receptors (TLRs) activate the signaling pathways linked to MAPK that lead to production of these cytokines. This study demonstrates that PCP‐induced production of IL‐1β and IL‐6 is dependent on TLR4 and TLR8, and independent of TLR1/2, TLR2, and TLR3. Additionally, DBT‐induced IL‐6 production depends on TLR1/2, whereas IL‐1β production does not. Blocking the TLR‐linked adapter protein, MyD88, lead to a loss of both PCP and DBT stimulation of IL‐1β and IL‐6. These findings indicate that both PCP and DBT interact with selected TLRs as part of their mechanisms of elevating the levels of critical pro‐inflammatory cytokines, which may contribute to chronic inflammation and its related pathologies.
- 17 September 2024
- Published by Wiley in Journal of Applied Toxicology
- Vol. 45 (2) , 273-287
Flame retardant, hexabromocyclododecane, increases production of pro‐inflammatory cytokines, interleukin 1‐beta and interleukin 6, in human immune cells
Hexabromocyclododecane (HBCD) is an environmental contaminant due to its use as a flame retardant in a variety of applications ranging from building insulation, furniture upholstery, and housing for appliances and electronics. HBCD is found in wildlife, human breastmilk, and serum. Interleukin 1‐beta (IL‐1β) and interleukin 6 (IL‐6) are pro‐inflammatory cytokines, whose dysregulation is associated with chronic inflammation and the pathologies that result, such as tumor growth, rheumatoid arthritis, Crohn's disease, and multiple sclerosis. HBCD has been shown to increase the secretion of both IL‐1β and IL‐6 from human immune cells. However, it is not clear if these increases are due solely to HBCD effects on the secretory process or whether it is stimulating cellular production of IL‐1β and IL‐6. This study examines if HBCD can increase the production of IL‐1β and IL‐6 by immune cells by simultaneously assessing secreted levels and cellular levels of these cytokines. Additionally, the mechanisms for any observed changes in production are investigated. Peripheral blood mononuclear cells were exposed to HBCD over a range of concentrations and lengths of exposure. HBCD was found to stimulate IL‐1β and IL‐6 production after 6 hrs. of exposure and production was sustained and intensified at 24 hrs. This increase in IL‐1β and IL‐6 production appears to, in part, be a result of increased mRNA expression. Additionally, the MAPK pathways, specifically the p38 and p44/42 pathways, appear to be required for HBCD‐induced increases in IL‐1β and IL‐6 production.
- 17 September 2024
- Published by Wiley in Journal of Applied Toxicology
- Vol. 45 (2) , 273-287
Flame retardant, hexabromocyclododecane, increases production of pro‐inflammatory cytokines, interleukin 1‐beta and interleukin 6, in human immune cells
Hexabromocyclododecane (HBCD) is an environmental contaminant due to its use as a flame retardant in a variety of applications ranging from building insulation, furniture upholstery, and housing for appliances and electronics. HBCD is found in wildlife, human breastmilk, and serum. Interleukin 1‐beta (IL‐1β) and interleukin 6 (IL‐6) are pro‐inflammatory cytokines, whose dysregulation is associated with chronic inflammation and the pathologies that result, such as tumor growth, rheumatoid arthritis, Crohn's disease, and multiple sclerosis. HBCD has been shown to increase the secretion of both IL‐1β and IL‐6 from human immune cells. However, it is not clear if these increases are due solely to HBCD effects on the secretory process or whether it is stimulating cellular production of IL‐1β and IL‐6. This study examines if HBCD can increase the production of IL‐1β and IL‐6 by immune cells by simultaneously assessing secreted levels and cellular levels of these cytokines. Additionally, the mechanisms for any observed changes in production are investigated. Peripheral blood mononuclear cells were exposed to HBCD over a range of concentrations and lengths of exposure. HBCD was found to stimulate IL‐1β and IL‐6 production after 6 hrs. of exposure and production was sustained and intensified at 24 hrs. This increase in IL‐1β and IL‐6 production appears to, in part, be a result of increased mRNA expression. Additionally, the MAPK pathways, specifically the p38 and p44/42 pathways, appear to be required for HBCD‐induced increases in IL‐1β and IL‐6 production.
- 6 December 2023
- Published by Springer Nature in Archives of Toxicology
- Vol. 98 (3) , 883-895
Interleukin 1β and interleukin 6 production in human immune cells is stimulated by the antibacterial compound Triclosan
Triclosan (TCS) is an antimicrobial compound widely used in personal hygiene products such as mouthwash and toothpaste; and has been found in human blood, breast milk, and urine. Interleukin (IL)-6 and IL-1 beta (IL-1β) are pro-inflammatory cytokines regulating cell growth, tissue repair, and immune function; increased levels of each have been associated with many diseases, including cancer. Previous studies showed that TCS at concentrations between 0.05 and 5 µM consistently increased the secretion of IL-1β and IL-6 from human immune cells within 24 h of exposure. The current study demonstrates that this increase in secretion was not due simply to release of existing stores but was due to an increase in cellular production/levels (both secreted and intracellular levels) of each of these cytokines. Production of IL-1β and IL-6 was increased by exposure to one or more concentration of TCS at each length of exposure (10 min, 30 min, 6 h, and 24 h). TCS-induced stimulation of cytokine production was shown to be dependent on the mitogen-activated protein kinase (MAPK) p44/42 (ERK 1/2). It was also shown that these TCS-induced increases in IL-1β and IL6 production were accompanied by increased mRNA for IL-1β and IL-6. The ability of TCS to increase production indicates that rather than activating a self-limiting process of depleting cells of already existing stores of IL-1β or IL-6, TCS can stimulate a process that has the capacity to provide sustained production of these cytokines and thus may lead to chronic inflammation and its pathological consequences.
- 6 December 2023
- Published by Springer Nature in Archives of Toxicology
- Vol. 98 (3) , 883-895
Interleukin 1β and interleukin 6 production in human immune cells is stimulated by the antibacterial compound Triclosan
Triclosan (TCS) is an antimicrobial compound widely used in personal hygiene products such as mouthwash and toothpaste; and has been found in human blood, breast milk, and urine. Interleukin (IL)-6 and IL-1 beta (IL-1β) are pro-inflammatory cytokines regulating cell growth, tissue repair, and immune function; increased levels of each have been associated with many diseases, including cancer. Previous studies showed that TCS at concentrations between 0.05 and 5 µM consistently increased the secretion of IL-1β and IL-6 from human immune cells within 24 h of exposure. The current study demonstrates that this increase in secretion was not due simply to release of existing stores but was due to an increase in cellular production/levels (both secreted and intracellular levels) of each of these cytokines. Production of IL-1β and IL-6 was increased by exposure to one or more concentration of TCS at each length of exposure (10 min, 30 min, 6 h, and 24 h). TCS-induced stimulation of cytokine production was shown to be dependent on the mitogen-activated protein kinase (MAPK) p44/42 (ERK 1/2). It was also shown that these TCS-induced increases in IL-1β and IL6 production were accompanied by increased mRNA for IL-1β and IL-6. The ability of TCS to increase production indicates that rather than activating a self-limiting process of depleting cells of already existing stores of IL-1β or IL-6, TCS can stimulate a process that has the capacity to provide sustained production of these cytokines and thus may lead to chronic inflammation and its pathological consequences.
- Open Access
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S726
Abstract 1568: Comparison of TLR4 and TLR1/2 in Pentachlorophenol Induced Stimulation of IL-1β in Human Immune Cells
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S726
Open AccessAbstract 1568: Comparison of TLR4 and TLR1/2 in Pentachlorophenol Induced Stimulation of IL-1β in Human Immune Cells
- Open Access
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S790-S791
Abstract 2444: Antibacterial Agent, Triclosan (TCS), Alters the Production of Pro-Inflammatory Cytokine Interleukin 1 beta from Human Immune Cells: The Role of Mitogen-Activated Protein Kinases
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S790-S791
Open AccessAbstract 2444: Antibacterial Agent, Triclosan (TCS), Alters the Production of Pro-Inflammatory Cytokine Interleukin 1 beta from Human Immune Cells: The Role of Mitogen-Activated Protein Kinases
- Open Access
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S719
Abstract 1478: Hexabromocyclododecane (HBCD) Increases Production of Pro-inflammatory Cytokines Interleukin 1 beta (IL-1β) and Interleukin 6 (IL-6) in Human Peripheral Blood Mononuclear Cells (PBMCs)
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S719
Open AccessAbstract 1478: Hexabromocyclododecane (HBCD) Increases Production of Pro-inflammatory Cytokines Interleukin 1 beta (IL-1β) and Interleukin 6 (IL-6) in Human Peripheral Blood Mononuclear Cells (PBMCs)
- 14 November 2022
- Published by Springer Nature in Archives of Toxicology
- Vol. 97 (2) , 469-493
Organotin and organochlorine toxicants activate key translational regulatory proteins in human immune cells
Environmental contaminant exposures occur due to the widespread use of synthetic chemicals. Tributyltin (TBT), dibutyltin (DBT), and pentachlorophenol (PCP) are each used in a variety of applications, including antifouling paints and stabilizers in certain plastics. Each of these compounds has been found in human blood, as well as other tissues, and they have been shown to stimulate pro-inflammatory cytokine production in human immune cells, Inflammatory cytokines mediate response to injury or infection. However, if their levels are increased in the absence of an appropriate stimulus, chronic inflammation can occur. Chronic inflammation is associated with a number of pathologies including cancer. Stimulation of pro-inflammatory cytokine production by these toxicants is dependent on activation of ERK 1/2 and/or p38 MAPK pathways. MAPK pathways have the capacity to regulate translation by increasing phosphorylation of key translation regulatory proteins. There have been no previous studies examining the effects of TBT, DBT, or PCP on translation. The current study shows that ribosomal protein S6 (S6), eukaryotic initiation factor 4B (eIF4B), and eIF4E are phosphorylated (activated) and/or their total levels are elevated in response to each of these compounds at concentrations found in human blood. Activation/increased levels of translational proteins occurred at concentrations of the compounds that have been shown to elevate pro-inflammatory cytokine production, but where there is no increase in mRNA for those proteins was seen. Compound-stimulated increases in translation appear to be part of the mechanism by which they elevate protein production in immune cells.
- 14 November 2022
- Published by Springer Nature in Archives of Toxicology
- Vol. 97 (2) , 469-493
Organotin and organochlorine toxicants activate key translational regulatory proteins in human immune cells
Environmental contaminant exposures occur due to the widespread use of synthetic chemicals. Tributyltin (TBT), dibutyltin (DBT), and pentachlorophenol (PCP) are each used in a variety of applications, including antifouling paints and stabilizers in certain plastics. Each of these compounds has been found in human blood, as well as other tissues, and they have been shown to stimulate pro-inflammatory cytokine production in human immune cells, Inflammatory cytokines mediate response to injury or infection. However, if their levels are increased in the absence of an appropriate stimulus, chronic inflammation can occur. Chronic inflammation is associated with a number of pathologies including cancer. Stimulation of pro-inflammatory cytokine production by these toxicants is dependent on activation of ERK 1/2 and/or p38 MAPK pathways. MAPK pathways have the capacity to regulate translation by increasing phosphorylation of key translation regulatory proteins. There have been no previous studies examining the effects of TBT, DBT, or PCP on translation. The current study shows that ribosomal protein S6 (S6), eukaryotic initiation factor 4B (eIF4B), and eIF4E are phosphorylated (activated) and/or their total levels are elevated in response to each of these compounds at concentrations found in human blood. Activation/increased levels of translational proteins occurred at concentrations of the compounds that have been shown to elevate pro-inflammatory cytokine production, but where there is no increase in mRNA for those proteins was seen. Compound-stimulated increases in translation appear to be part of the mechanism by which they elevate protein production in immune cells.
- 9 April 2022
- Published by Elsevier in Toxicology
- Vol. 472, 153177
Toll-like receptors in the mechanism of tributyltin-induced production of pro-inflammatory cytokines, IL-1β and IL-6
- 9 April 2022
- Published by Elsevier in Toxicology
- Vol. 472, 153177
Toll-like receptors in the mechanism of tributyltin-induced production of pro-inflammatory cytokines, IL-1β and IL-6